CALC
CalciMedica, Inc.
$0.90
-0.06 (-5.86%)
At close · Jul 8
Market Cap
$14.22M
Shares
15,798,031
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.90
Open$0.94
Day$0.87–0.96
52W$0.46–7.20
Avg vol 30d2.4M
Short int276K · 1.7% float · 1.0d
Short vol22%
Last earningsMay 12, 2026
DataJun 2023–Jul 2026
Filing10-Q · May 12
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−60%
below
Price vs 50-day avg
+17%
above
RSI (14)
53
neutral
MACD trend
Positive
52-week position
7%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−6%
trailing
6-month return
−84%
trailing
YTD return
−86%
this year
Relative strength
−91%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Distributing
1 of 28 funds reported for Jun 30 · net -43.1K sh shares
Insider flow
Accumulating
Net +$200.0K over 90 days · 0% sells
Short interest
Rising
1.75% of float · ▲ +91.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
28 holders — mid 3-yr range
Squeeze score
47
elevated · 0–100
Fundamentals
EPS growth
−61%
Y/Y
Free cash flow
$-21.2M
Balance sheet
$11.5M
net cash
Quant / Vol
risk profile
Volatility
146%
annualized · 1-yr
Max drawdown
−92%
past year
ATR
14.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 9, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−60%
Bearish
Price vs 50-day avg
+17%
Bullish
RSI (14)
53
Neutral
MACD trend
Positive
Bullish
52-week position
7%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Distributing
1 of 28 funds reported for Jun 30 · net -43.1K sh shares
Insider flow
Accumulating
Net +$200.0K over 90 days · 0% sells
Short interest
Rising
1.75% of float · ▲ +91.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
28 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $0
Now $1 · 7%
52-wk high $7
vs 200-day avg -60%
vs 50-day avg +17%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CALC
this stock
CalciMedica, Inc.
|
$14.22M | -86.3% | — | — | 1.7% |
|
ONC
BeOne Medicines Ltd.
|
$446.53B | +1.7% | +22179.2% | 908.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.50B | +9.9% | +46.2% | 31.0 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.90B | -12.3% | +20.8% | 16.5 | 3.2% |
|
ARGX
Argenx SE
|
$57.20B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CALC | -12.6% | -6.1% | -83.8% | -12.6% | -86.3% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -12.4% | -6.9% | -91.2% | -12.4% | -95.7% |